Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01318954 · ClinicalTrials.gov registry record
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
A clinical trial, sponsored by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C..
- Completed
- Registry status
- 17
- Enrollment target
NCT01318954: Completed study, sponsored by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C..
NCT01318954 is a clinical trial that has completed, run by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01318954 has completed, sponsored by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C..
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This study will evaluate whether exhaled nitric oxide levels are affected by allergen immunotherapy ("allergy shots"). The investigators' hypothesis is that successful allergen immunotherapy may be accompanied by decreased exhaled nitric oxide levels.
Interventions
- BIOLOGICAL Allergen immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-06 |
What the finished NCT01318954 record still lists
NCT01318954 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Allergen immunotherapy is the first listed.
NCT01318954 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01318954 about?
NCT01318954 is a clinical study titled "The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis". This study will evaluate whether exhaled nitric oxide levels are affected by allergen immunotherapy ("allergy shots"). The investigators' hypothesis is that successful allergen immunotherapy may be accompanied by decreased exhaled nitric oxide levels.
What is the current status of trial NCT01318954?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2008-01. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01318954?
The interventions under investigation include: Allergen immunotherapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT01318954?
This trial is sponsored by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C., which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia